MicroSurgical Technology
Rubens Traldi Fonseca is an accomplished financial executive with extensive experience in various leadership roles, currently serving as Chief Financial Officer at MicroSurgical Technology since October 2022. Prior to this, Rubens held the position of FD at Cardios and HALMA Health and Optics Brazil from November 2017 to September 2022. Previous roles include Sr Manager Finance LATAM at Thermo Fisher Scientific, Brazil Controller at Nobel Biocare, and Controller & IT Manager at Radio Frequency Systems. Rubens has a proven track record in financial management, accounting, tax strategy, and operational controllership across diverse industries, supported by educational qualifications of an MBA from FGV - Fundação Getulio Vargas and a BBA from ESPM Escola Superior de Propaganda e Marketing.
MicroSurgical Technology
MST’s passion is creating exceptional products that improve vision for patients all over the world. We strive to equip surgeons with the most innovative tools available, enabling them to achieve the best possible outcomes for their patients. We constantly evolve to meet the distinct clinical needs of ophthalmic surgeons through our dedicated partnership with surgeon-designers, bringing innovation to ophthalmology. Every MST product meets the highest standards and is designed to instill confidence during surgery. The MST team invests extraordinary care and attention into all elements of our products—not only in function but also in packaging, look and feel, and ease of adoption into the practice. MST is a highly profitable and fast-growing company headquartered in Redmond, Washington. MST is one of over fifty operating companies that form Halma PLC, a UK-based conglomerate with over $1.5B in annual sales and $4.5B in market value. Halma is listed on the London Stock Exchange and is a member of the FTSE 100 index. Halma’s business philosophy is to maintain the operating companies’ autonomy and entrepreneurship while providing the financial, operational and employee development resources that a world-class multi-national has to offer.